For example, a clinical study suggested that downregulation of insulin signaling may occur during obesity before T2DM is developed due to hyperactivation of PH domain leucine-rich repeat-containing protein phosphatase (PHLPP-1) (36). This evidence concerns the gene PHLPP1 and obesity due to melanocortin 4 receptor deficiency.